NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nexgel's enterprise value was $56.72M on Oct 19, 2026, against $376.80M a year earlier. Over the last 5 years it ranged from $33.99M to $605.95M, with a median of $238.04M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $56.72M | -78.4% |
| 2025 | Dec 31, 2025 | $262.16M | -56.7% |
| 2024 | Dec 31, 2024 | $605.95M | +151.2% |
| 2023 | Dec 29, 2023 | $241.23M | +82.5% |
| 2022 | Dec 30, 2022 | $132.16M | -14.5% |
| 2021 | Dec 31, 2021 | $154.53M | – |